CanSino Biologics Inc. is a biotechnology company focused on developing, manufacturing, and commercializing high-quality vaccines for public health. Founded in Tianjin, China, the company is known for... CanSino Biologics Inc. is a biotechnology company focused on developing, manufacturing, and commercializing high-quality vaccines for public health. Founded in Tianjin, China, the company is known for its efforts in developing the adenovirus-based viral vector vaccine and other biologics that address significant medical needs. CanSino Biologics covers a wide range of therapeutic areas, including infectious diseases, cancer, and more, using cutting-edge technology and scientific innovation to enhance preventative healthcare. The company has a prominent role within the pharmaceutical industry, contributing to both domestic and international public health initiatives. CanSino Biologics' products are pivotal in controlling outbreaks and have positioned the company as a significant player in the global vaccine market by providing solutions against various diseases, supporting both community health and preparedness for emerging health threats.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

CanSino Biologics is not subject to EU Taxonomy reporting

Based on current regulatory requirements, CanSino Biologics is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review CanSino Biologics's data?

Start your 30-day free trial to request a data review for CanSino Biologics.

Start Free Trial

Legal Center Contact Us